Woman’s unexpected breast cancer battle reshapes life and priorities
Active Leader Confronts Arthritis, Loss of Mobility and Independence
Dermatology nurse helps patients beyond skin issues
October 10, 2026
Diet Key to Skin Health, Not Supplements Alone
October 8, 2026
FDA grants priority review to Genentech’s MS drug
September 30, 2026
CAR T-Cell Therapy Achieves Lasting Remission in Child’s Liver Cancer
September 23, 2026
Doctor Dispatches ❖ FEATURED
Diabetes Care Evolves Over Decades
Doctor Dispatches ❖ FEATURED
Canada to overhaul outdated cancer screening guidelines
Doctor Dispatches ❖ FEATURED
Immunovant Launches Phase 3 Trial for Myasthenia Gravis Drug
Doctor Dispatches ❖ FEATURED
Experts Offer Mentorship Advice for New Neurologists
Private Telehealth Expands Access for Canadian Patients
New study tests direct switch from IVIG to subcutaneous efgartigimod
New phase 4 study explores direct switch from IVIG to subcutaneous efgartigimod for CIDP patients without disease worsening, presented at…
October 2, 2026
New International Study Monitors Nipocalimab Use in Pregnancy
The PETUNIA study tracks nipocalimab pregnancy outcomes, monitoring pregnant people with myasthenia gravis, presented at the 2026 AANEM meeting.
October 1, 2026
FDA delays review of rare epilepsy drug
The FDA delays review of relutrigine, an experimental treatment for SCN2A/SCN8A-related epilepsy, pushing the decision date to December 27, 2026.
September 28, 2026
FDA approves first treatments for rare ataxia disorders
The FDA has approved the first treatments for rare ataxia disorders, including Omaveloxolone for Friedreich ataxia and levacetylleucine for ataxia-telangiectasi
September 26, 2026
Monocytes predict vaccine side effects
Monocytes may predict vaccine side effects in individuals after receiving an mRNA vaccine.
September 21, 2026
Dapagliflozin Reduces Heart Failure Risks, Regardless of Congestion
Dapagliflozin reduces heart failure risks regardless of congestion, according to the DAPA ACT HF-TIMI 68 trial.
September 19, 2026
Sotatercept Added to PAH Treatment Guidelines
New lung cancer drug dosing shows promise for patient convenience
Cancer rates rise among 9/11 survivors
Wellness Rounds
Surgeon speaks out on mental health struggles
Wellness Rounds
Over 100 Arthritis Types Categorized by Cause
Wellness Rounds
Breast cancer patient redefines treatment with control and curiosity
Mother Cares for Daughter with Young-Onset Breast Cancer
A mother's journey caring for her daughter with young-onset breast cancer, navigating rare and complex cancer care for young adults…
October 14, 2026
No One Right Way to Feed Baby
Baby feeding choices with expert insights, recognizing there's no single right way to nourish your newborn effectively.
October 6, 2026
Trappsol Cyclo trial misses primary goal, subgroup benefits
Trappsol Cyclo trial missed primary goal in Niemann-Pick disease, but subgroup benefits show signs of slowing disease progression in a…
October 3, 2026
Latest News
Sotatercept Added to PAH Treatment Guidelines
Sotatercept is added to PAH treatment guidelines as an additional therapy for patients.
By Nadia Yusof September 17, 2026
Adjuvant Osimertinib Shows 8-Year Survival Benefit in Lung Cancer
Adjuvant osimertinib offers an 8-year survival benefit for resected EGFR-mutated NSCLC patients, per the ADAURA trial at the…
By E Hughes September 16, 2026
Ivonescimab improves survival over pembrolizumab in advanced lung cancer
Ivonescimab improves survival over pembrolizumab for advanced NSCLC patients, per the HARMONi-2 trial presented at WCLC 2026.
By Aliya Hassan September 15, 2026
New lung cancer drug dosing shows promise for patient convenience
New lung cancer drug dosing (Tarlatamab) offers pharmacists flexibility with every 3-4 week schedules, maintaining efficacy per DeLLphi-309…
By Nadia Yusof September 14, 2026
Cancer rates rise among 9/11 survivors
9/11 survivors see cancer cases surge, with a new study reporting a 2.5‑fold rise in diagnoses since 2019…
By Aliya Hassan September 12, 2026
Pharmacists fill vaccination gap as measles cases surge
Pharmacists are filling the measles vaccination gap as US cases surge to 2,134 in 2026. Discover how pharmacy…
By E Hughes September 11, 2026
Tozorakimab cuts COPD flare-ups in late-stage trials
Tozorakimab significantly reduces COPD flare-ups in late-stage trials, offering new hope for patients with chronic obstructive pulmonary disease.
By Nadia Yusof September 10, 2026
MedTech Devices Evolve, Pushing Materiovigilance Ahead
Materiovigilance helps monitor safety issues with medical devices as medtech evolves, ensuring patient safety through continuous evaluation of…
By Nadia Yusof September 9, 2026
AI tools improve medical device safety checks
AI tools are transforming medical device safety checks by analyzing thousands of monthly complaints for faster, more accurate…
By Nadia Yusof September 8, 2026
MedTech firms advance lean manufacturing techniques
MedTech firms are revolutionizing lean manufacturing with digital integration and precision techniques for medical device production.
By E Hughes September 7, 2026